Hematology Diagnostic Devices Market Size, Insights, Outlook, Overview By 2024-2033

Overview and Scope

Hematology diagnostic devices and equipment are used to diagnose diseases related to blood, vascular systems, bone marrow, autoimmune disorders, and hemostasis.

Sizing and Forecast

The hematology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $2.15 billion in 2023 to $2.41 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to clinical diagnostics, blood banking, oncology and hematological disorders, monitoring disease progression.

The hematology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $3.7 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to aging population, personalized medicine, rising blood-related disorders, hematological biomarkers. Major trends in the forecast period include technological advancements, point-of-care hematology testing, automation and integration, telemedicine and remote monitoring.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Segmentation & Regional Insights

The hematology diagnostic devices and equipment market covered in this report is segmented –

1) By Product: Instruments, Consumables

2) By Instruments: Analyzers, Flow cytometers, Other Instruments

3) By Consumables: Reagents, Stains, Other Consumables

4) By Application: Drug Testing, Auto-Immune Disease, Cancer, Diabetes Mellitus, Infectious Disease, Other Applications

5) By End User: Hospitals, Specialized Diagnostic Centers, Specialized Research Institutes

Top Major Players:
Abbott Diagnostics
Beckman Coulter Inc
Bio-Rad Laboratories Inc.
Drucker Diagnostics Inc.
Horiba Ltd
Instrumentation Laboratory Inc

North America was the largest region in the global hematology diagnostics devices and equipment market in 2023.

North America  was the largest region in the global hematology diagnostics devices and equipment market in 2023. Asia-Pacific was the second-largest region in the hematology diagnostics devices and equipment market. The regions covered in the hematology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2536&type=smp

Major Driver Impacting Market Growth

Hematology diagnostic devices are driven by the increase in the prevalence of blood disorders. Hematology diagnostic devices are widely used to identify the type of blood disorder. A blood disorder is a condition which is impacting the count of the blood cells like red blood cells, white blood cells, platelets, etc. Blood disorders affect millions of people each year across the world irrespective of age, race, and sex. For instance, according to the World Health Organization, Hemoglobin disorder is affects 75% of the total births globally and the prevalence of Anemia is 12.7% in men.

Key Industry Players

 Major companies operating in the hematology diagnostic devices and equipment market include <b> Abbott Diagnostics, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Drucker Diagnostics Inc., Horiba Ltd., Instrumentation Laboratory Inc., Siemens Healthcare, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., F.Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., HemoCue AB, Mindray Medical International Limited, NORMA Group, Danaher Corporation, Edan Instruments Inc., Novo Nordisk, Sysmex Corporation, Fluidigm Corporation, CellaVision, Maccura Biotechnology Co., DY mind Biotech, Balio Diagnostics, BioSystems Diagnostics Pvt. Ltd., Wiener Lab, Accurex Biomedical Pvt. Ltd., ARKRAY USA, Boule Diagnostics AB, DermaFlow, Diagnostics Holdings, Diatron Group, EKF Diagnostics Holdings, Grifols, S.A., ICU Medical Inc., Nihon Kohden Corporation, Ortho Clinical Diagnostics, PixCell Medical, STRATEC Biomedical AG, Terumo BCT, Z-Medica Corporation </b>

The hematology diagnostic devices and equipment market report table of contents includes:

1. Executive Summary
2. Hematology Diagnostic Devices And Equipment Market Characteristics
3. Hematology Diagnostic Devices And Equipment Market Trends And Strategies
4. Hematology Diagnostic Devices And Equipment Market – Macro Economic Scenario
5. Global Hematology Diagnostic Devices And Equipment Market Size and Growth
…
31. Global Hematology Diagnostic Devices And Equipment Market Competitive Benchmarking
32. Global Hematology Diagnostic Devices And Equipment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hematology Diagnostic Devices And Equipment Market
34.Hematology Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model